BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Org E, Mehrabian M, Lusis AJ. Unraveling the environmental and genetic interactions in atherosclerosis: Central role of the gut microbiota. Atherosclerosis. 2015;241:387-399. [PMID: 26071662 DOI: 10.1016/j.atherosclerosis.2015.05.035] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 7.1] [Reference Citation Analysis]
Number Citing Articles
1 Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Genome Biol. 2017;18:83. [PMID: 28476144 DOI: 10.1186/s13059-017-1215-1] [Cited by in Crossref: 596] [Cited by in F6Publishing: 477] [Article Influence: 119.2] [Reference Citation Analysis]
2 Deng Q, Li XX, Fang Y, Chen X, Xue J. Therapeutic Potential of Quercetin as an Antiatherosclerotic Agent in Atherosclerotic Cardiovascular Disease: A Review. Evid Based Complement Alternat Med 2020;2020:5926381. [PMID: 32565865 DOI: 10.1155/2020/5926381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
3 Poznyak AV, Ivanova EA, Sobenin IA, Yet SF, Orekhov AN. The Role of Mitochondria in Cardiovascular Diseases. Biology (Basel) 2020;9:E137. [PMID: 32630516 DOI: 10.3390/biology9060137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
4 Huo W, Feng Z, Hu S, Cui L, Qiao T, Dai L, Qi P, Zhang L, Liu Y, Li J. Effects of polysaccharides from wild morels on immune response and gut microbiota composition in non-treated and cyclophosphamide-treated mice. Food Funct 2020;11:4291-303. [PMID: 32356856 DOI: 10.1039/d0fo00597e] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
5 Serena C, Ceperuelo-Mallafré V, Keiran N, Queipo-Ortuño MI, Bernal R, Gomez-Huelgas R, Urpi-Sarda M, Sabater M, Pérez-Brocal V, Andrés-Lacueva C, Moya A, Tinahones FJ, Fernández-Real JM, Vendrell J, Fernández-Veledo S. Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota. ISME J 2018;12:1642-57. [PMID: 29434314 DOI: 10.1038/s41396-018-0068-2] [Cited by in Crossref: 99] [Cited by in F6Publishing: 102] [Article Influence: 24.8] [Reference Citation Analysis]
6 Li Q, Gao B, Siqin B, He Q, Zhang R, Meng X, Zhang N, Zhang N, Li M. Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids. Front Pharmacol 2021;12:651926. [PMID: 34220497 DOI: 10.3389/fphar.2021.651926] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Jameson E, Quareshy M, Chen Y. Methodological considerations for the identification of choline and carnitine-degrading bacteria in the gut. Methods 2018;149:42-8. [PMID: 29684641 DOI: 10.1016/j.ymeth.2018.03.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
8 Cui L, Zhao T, Hu H, Zhang W, Hua X. Association Study of Gut Flora in Coronary Heart Disease through High-Throughput Sequencing. Biomed Res Int 2017;2017:3796359. [PMID: 28497047 DOI: 10.1155/2017/3796359] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
9 Chen Y, Chen L, Zhou Q. Genetic association between eNOS gene polymorphisms and risk of carotid atherosclerosis : A meta-analysis. Herz 2021;46:253-64. [PMID: 33095272 DOI: 10.1007/s00059-020-04995-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 de Aguiar Vallim TQ, Tarling EJ. mInd the gAP: Intestinal Alkaline Phosphatase Puts the Breaks on Atherosclerosis. Circ Res 2021;128:1660-2. [PMID: 34043422 DOI: 10.1161/CIRCRESAHA.121.319307] [Reference Citation Analysis]
11 Getz GS, Reardon CA. Natural killer T cells in atherosclerosis. Nat Rev Cardiol 2017;14:304-14. [DOI: 10.1038/nrcardio.2017.2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 8.2] [Reference Citation Analysis]
12 Lv Z, Shan X, Tu Q, Wang J, Chen J, Yang Y. Ginkgolide B treatment regulated intestinal flora to improve high-fat diet induced atherosclerosis in ApoE−/− mice. Biomedicine & Pharmacotherapy 2021;134:111100. [DOI: 10.1016/j.biopha.2020.111100] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Lusis AJ, Seldin MM, Allayee H, Bennett BJ, Civelek M, Davis RC, Eskin E, Farber CR, Hui S, Mehrabian M, Norheim F, Pan C, Parks B, Rau CD, Smith DJ, Vallim T, Wang Y, Wang J. The Hybrid Mouse Diversity Panel: a resource for systems genetics analyses of metabolic and cardiovascular traits. J Lipid Res 2016;57:925-42. [PMID: 27099397 DOI: 10.1194/jlr.R066944] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 11.7] [Reference Citation Analysis]
14 Ahmed S, Spence JD. Sex differences in the intestinal microbiome: interactions with risk factors for atherosclerosis and cardiovascular disease. Biol Sex Differ 2021;12:35. [PMID: 34001264 DOI: 10.1186/s13293-021-00378-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Constipation and risk of death and cardiovascular events. Atherosclerosis 2019;281:114-20. [PMID: 30658186 DOI: 10.1016/j.atherosclerosis.2018.12.021] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
16 Schenck LP, Beck PL, MacDonald JA. Gastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infection. World J Gastrointest Pathophysiol 2015; 6(4): 169-180 [PMID: 26600975 DOI: 10.4291/wjgp.v6.i4.169] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
17 Mantziaris V, Kolios G. Gut Microbiota, Atherosclerosis, and Therapeutic Targets. Crit Pathw Cardiol 2019;18:139-42. [PMID: 31348074 DOI: 10.1097/HPC.0000000000000187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Haissman JM, Haugaard AK, Ostrowski SR, Berge RK, Hov JR, Trøseid M, Nielsen SD. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection. BMC Infect Dis 2017;17:445. [PMID: 28645263 DOI: 10.1186/s12879-017-2547-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
19 Kühn T, Rohrmann S, Sookthai D, Johnson T, Katzke V, Kaaks R, von Eckardstein A, Müller D. Intra-individual variation of plasma trimethylamine-N-oxide (TMAO), betaine and choline over 1 year. Clinical Chemistry and Laboratory Medicine (CCLM) 2017;55. [DOI: 10.1515/cclm-2016-0374] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 10.2] [Reference Citation Analysis]
20 Sanchez-Alcoholado L, Castellano-Castillo D, Jordán-Martínez L, Moreno-Indias I, Cardila-Cruz P, Elena D, Muñoz-Garcia AJ, Queipo-Ortuño MI, Jimenez-Navarro M. Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes Mellitus. Front Microbiol 2017;8:1936. [PMID: 29051757 DOI: 10.3389/fmicb.2017.01936] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
21 Tinkov AA, Filippini T, Ajsuvakova OP, Skalnaya MG, Aaseth J, Bjørklund G, Gatiatulina ER, Popova EV, Nemereshina ON, Huang PT, Vinceti M, Skalny AV. Cadmium and atherosclerosis: A review of toxicological mechanisms and a meta-analysis of epidemiologic studies. Environ Res 2018;162:240-60. [PMID: 29358116 DOI: 10.1016/j.envres.2018.01.008] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 14.3] [Reference Citation Analysis]
22 Ribeiro FM, Ribeiro CFA, G ACM, Castro AP, Almeida JA, Franco OL, Petriz BA. Limited Effects of Low-to-Moderate Aerobic Exercise on the Gut Microbiota of Mice Subjected to a High-Fat Diet. Nutrients 2019;11:E149. [PMID: 30641996 DOI: 10.3390/nu11010149] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
23 Wang Z, Koonen D, Hofker M, Fu J. Gut microbiome and lipid metabolism: from associations to mechanisms. Current Opinion in Lipidology 2016;27:216-24. [DOI: 10.1097/mol.0000000000000308] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
24 Barouei J, Bendiks Z, Martinic A, Mishchuk D, Heeney D, Hsieh YH, Kieffer D, Zaragoza J, Martin R, Slupsky C, Marco ML. Microbiota, metabolome, and immune alterations in obese mice fed a high-fat diet containing type 2 resistant starch. Mol Nutr Food Res 2017;61. [PMID: 28736992 DOI: 10.1002/mnfr.201700184] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]
25 Xavier-santos D, Bedani R, Lima ED, Saad SMI. Impact of probiotics and prebiotics targeting metabolic syndrome. Journal of Functional Foods 2020;64:103666. [DOI: 10.1016/j.jff.2019.103666] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 6.5] [Reference Citation Analysis]
26 Liu W, Feng H, Zheng S, Xu S, Massey IY, Zhang C, Wang X, Yang F. Pb Toxicity on Gut Physiology and Microbiota. Front Physiol 2021;12:574913. [PMID: 33746764 DOI: 10.3389/fphys.2021.574913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 de Menezes Pereira M, Sant'ana Santos TP, Cabral MS, Sampaio GP, Aras R, Ribeiro P, Atta AM. Th17 immune responses in Brazilian dyslipidemic patients with atherosclerosis. International Immunopharmacology 2018;56:51-7. [DOI: 10.1016/j.intimp.2018.01.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
28 Gao J, Yan KT, Wang JX, Dou J, Wang J, Ren M, Ma J, Zhang X, Liu Y. Gut microbial taxa as potential predictive biomarkers for acute coronary syndrome and post-STEMI cardiovascular events. Sci Rep 2020;10:2639. [PMID: 32060329 DOI: 10.1038/s41598-020-59235-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
29 Li R, Yang J, Saffari A, Jacobs J, Baek KI, Hough G, Larauche MH, Ma J, Jen N, Moussaoui N, Zhou B, Kang H, Reddy S, Henning SM, Campen MJ, Pisegna J, Li Z, Fogelman AM, Sioutas C, Navab M, Hsiai TK. Ambient Ultrafine Particle Ingestion Alters Gut Microbiota in Association with Increased Atherogenic Lipid Metabolites. Sci Rep 2017;7:42906. [PMID: 28211537 DOI: 10.1038/srep42906] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 8.0] [Reference Citation Analysis]
30 Barrington WT, Lusis AJ. Atherosclerosis: Association between the gut microbiome and atherosclerosis. Nat Rev Cardiol 2017;14:699-700. [PMID: 29099096 DOI: 10.1038/nrcardio.2017.169] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
31 Yang K, Xu M, Cao J, Zhu Q, Rahman M, Holmén BA, Fukagawa NK, Zhu J. Ultrafine particles altered gut microbial population and metabolic profiles in a sex-specific manner in an obese mouse model. Sci Rep 2021;11:6906. [PMID: 33767227 DOI: 10.1038/s41598-021-85784-4] [Reference Citation Analysis]
32 Ponziani FR, Pompili M, Di Stasio E, Zocco MA, Gasbarrini A, Flore R. Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms. World J Gastroenterol 2017; 23(7): 1241-1249 [PMID: 28275304 DOI: 10.3748/wjg.v23.i7.1241] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
33 Lu CC, Hu ZB, Wang R, Hong ZH, Lu J, Chen PP, Zhang JX, Li XQ, Yuan BY, Huang SJ, Ruan XZ, Liu BC, Ma KL. Gut microbiota dysbiosis-induced activation of the intrarenal renin-angiotensin system is involved in kidney injuries in rat diabetic nephropathy. Acta Pharmacol Sin 2020;41:1111-8. [PMID: 32203081 DOI: 10.1038/s41401-019-0326-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Jia PP, Junaid M, Wen PP, Yang YF, Li WG, Yang XG, Pei DS. Role of germ-free animal models in understanding interactions of gut microbiota to host and environmental health: A special reference to zebrafish. Environ Pollut 2021;279:116925. [PMID: 33744636 DOI: 10.1016/j.envpol.2021.116925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Yamamoto EA, Jørgensen TN. Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity. Front Immunol 2019;10:3141. [PMID: 32038645 DOI: 10.3389/fimmu.2019.03141] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 14.0] [Reference Citation Analysis]
36 Feng J, Cavallero S, Hsiai T, Li R. Impact of air pollution on intestinal redox lipidome and microbiome. Free Radic Biol Med 2020;151:99-110. [PMID: 31904545 DOI: 10.1016/j.freeradbiomed.2019.12.044] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
37 Gregersen I, Holm S, Dahl TB, Halvorsen B, Aukrust P. A focus on inflammation as a major risk factor for atherosclerotic cardiovascular diseases. Expert Rev Cardiovasc Ther 2016;14:391-403. [PMID: 26641944 DOI: 10.1586/14779072.2016.1128828] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
38 Ottosson F, Brunkwall L, Ericson U, Nilsson PM, Almgren P, Fernandez C, Melander O, Orho-Melander M. Connection Between BMI-Related Plasma Metabolite Profile and Gut Microbiota. J Clin Endocrinol Metab. 2018;103:1491-1501. [PMID: 29409054 DOI: 10.1210/jc.2017-02114] [Cited by in Crossref: 87] [Cited by in F6Publishing: 87] [Article Influence: 21.8] [Reference Citation Analysis]
39 Getz GS, Reardon CA. Diet, Microbes, and Murine Atherosclerosis. Arterioscler Thromb Vasc Biol 2018;38:2269-71. [PMID: 30354225 DOI: 10.1161/ATVBAHA.118.311513] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
40 Xu C, Jiang Z, Liu Q, Liu H, Gu A. Estrogen receptor beta mediates hepatotoxicity induced by perfluorooctane sulfonate in mouse. Environ Sci Pollut Res 2017;24:13414-23. [DOI: 10.1007/s11356-017-8943-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
41 Zia Y, Al Rajabi A, Mi S, Ju T, Leonard K, Nelson R, Thiesen A, Willing BP, Field CJ, Curtis JM, van der Veen JN, Jacobs RL. Hepatic Expression of PEMT, but Not Dietary Choline Supplementation, Reverses the Protection against Atherosclerosis in Pemt−/−/Ldlr−/− Mice. The Journal of Nutrition 2018;148:1513-20. [DOI: 10.1093/jn/nxy165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
42 Emoto T, Yamashita T, Sasaki N, Hirota Y, Hayashi T, So A, Kasahara K, Yodoi K, Matsumoto T, Mizoguchi T, Ogawa W, Hirata K. Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease. J Atheroscler Thromb. 2016;23:908-921. [PMID: 26947598 DOI: 10.5551/jat.32672] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 17.7] [Reference Citation Analysis]
43 Li XS, Obeid S, Klingenberg R, Gencer B, Mach F, Räber L, Windecker S, Rodondi N, Nanchen D, Muller O, Miranda MX, Matter CM, Wu Y, Li L, Wang Z, Alamri HS, Gogonea V, Chung YM, Tang WH, Hazen SL, Lüscher TF. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. Eur Heart J 2017;38:814-24. [PMID: 28077467 DOI: 10.1093/eurheartj/ehw582] [Cited by in Crossref: 62] [Cited by in F6Publishing: 121] [Article Influence: 15.5] [Reference Citation Analysis]
44 Wu DN, Guan L, Jiang YX, Ma SH, Sun YN, Lei HT, Yang WF, Wang QF. Microbiome and metabonomics study of quercetin for the treatment of atherosclerosis. Cardiovasc Diagn Ther 2019;9:545-60. [PMID: 32038944 DOI: 10.21037/cdt.2019.12.04] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
45 Chen C, Huang X, Fang S, Yang H, He M, Zhao Y, Huang L. Contribution of Host Genetics to the Variation of Microbial Composition of Cecum Lumen and Feces in Pigs. Front Microbiol 2018;9:2626. [PMID: 30429843 DOI: 10.3389/fmicb.2018.02626] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
46 Din AU, Hassan A, Zhu Y, Yin T, Gregersen H, Wang G. Amelioration of TMAO through probiotics and its potential role in atherosclerosis. Appl Microbiol Biotechnol 2019;103:9217-28. [PMID: 31655880 DOI: 10.1007/s00253-019-10142-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
47 Dong Z, Liang Z, Guo M, Hu S, Shen Z, Hai X. The Association between Plasma Levels of Trimethylamine N-Oxide and the Risk of Coronary Heart Disease in Chinese Patients with or without Type 2 Diabetes Mellitus. Dis Markers 2018;2018:1578320. [PMID: 30159101 DOI: 10.1155/2018/1578320] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
48 Anlu W, Dongcheng C, He Z, Qiuyi L, Yan Z, Yu Q, Hao X, Keji C. Using herbal medicine to target the “microbiota-metabolism-immunity” axis as possible therapy for cardiovascular disease. Pharmacological Research 2019;142:205-22. [DOI: 10.1016/j.phrs.2019.02.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
49 Onal EM, Afsar B, Covic A, Vaziri ND, Kanbay M. Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease. Hypertens Res 2019;42:123-40. [PMID: 30504819 DOI: 10.1038/s41440-018-0144-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]